ATLASATLAS fair value
SEK 19.90
Above fair value · 36% premium
Range: SEK 17–SEK 23Fair valuePrice
Carasent (CARA.ST)
Carasent stock price today, ATLAS forecast and fair value
Healthcare · Health Information Services · Nasdaq Stockholm · Sweden
SEK 27.00▲ +0.19%
Prices as of Oct 27, 2026 · SEK
Chance of rising in 1 month
50%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Carasent in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Carasent
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Carasent's fair value at about SEK 19.90 per share (reasonable range: SEK 16.81 to SEK 23.32). At SEK 27.00, the stock trades 36% above it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is low. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Carasent a 50% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between SEK 25.41 and SEK 28.72; in 9 out of 10, between SEK 22.79 and SEK 32.02. Estimated annual volatility is 30%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- SEK 1.8B
- Market cap (USD)
- $183M
- P/E ratio
- 51.7
- 52-week high
- SEK 29.45
- 52-week low
- SEK 21.70
- Revenue (12 months)
- SEK 390M
- Gross margin
- 83.4%
- Operating margin
- 8.4%
- Net margin
- 10.1%
- Beta
- 0.26
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Carasent sits above fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks CARA.ST has traded between SEK 21.70 and SEK 29.45. Today it is 8.3% below that high and 24% above its low.
On the business: net margin is 10.1%; it trades at 51.7 times earnings.
Its beta is 0.26: it tends to move less than the market.
About the company
Carasent AB (publ) provides cloud based electronic health record (EHR) systems solutions and platform services for healthcare sector in Nordics and Germany. The company offers Webdoc, Webcur, Metodika, Ad Curis, Ad Opus, and Data-AL solutions.
Want to see everything about Carasent?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Carasent (CARA.ST) fair value?
About SEK 19.90 per share according to ATLAS (reasonable range: SEK 16.81 to SEK 23.32). With the stock at SEK 27.00, it is 36% above it.
What is the chance CARA.ST goes up next month?
50%: close to a coin flip. In half of the simulated outcomes, CARA.ST ends the month between SEK 25.41 and SEK 28.72.
How big is Carasent and what is its P/E ratio?
Carasent's market capitalization is SEK 1.8B. Its price-to-earnings (P/E) ratio is 51.7: you pay SEK 51.7 for each SEK 1.00 of yearly earnings.
How volatile is CARA.ST?
ATLAS estimates annual volatility at 30%. In a typical month, half of the outcomes end between SEK 25.41 and SEK 28.72.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer